Holen Sie sich die Stockscreener-App
1.18
0.43%
0.01
Schlusskurs vom Vortag:
$1.17
Offen:
$1.17
24-Stunden-Volumen:
502.69K
Relative Volume:
1.17
Marktkapitalisierung:
$92.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-49.87M
KGV:
-0.6008
EPS:
-1.964
Netto-Cashflow:
$-19.36M
1W Leistung:
-13.28%
1M Leistung:
-25.63%
6M Leistung:
-26.56%
1J Leistung:
-27.91%
1-Tages-Spanne:
$1.135
$1.19
1-Wochen-Bereich:
$1.00
$1.20
52-Wochen-Spanne:
$1.00
$2.40
Rein Therapeutics Inc Stock (RNTX) Company Profile
Firmenname
Rein Therapeutics Inc
Sektor
Branche
Telefon
(737) 802-1989
Adresse
12407 N. MOPAC EXPY., AUSTIN
Compare RNTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.18 | 91.31M | 0 | -49.87M | -19.36M | -1.964 |
VRTX
Vertex Pharmaceuticals Inc
|
426.46 | 108.54B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
709.05 | 75.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
782.49 | 50.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.44 | 40.45B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.71 | 32.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-07-24 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-24 | Eingeleitet | Jefferies | Buy |
| 2017-07-24 | Eingeleitet | William Blair | Outperform |
Rein Therapeutics Inc Aktie (RNTX) Neueste Nachrichten
Rein Therapeutics Prices $50 Million Public Equity Offering - TipRanks
Rein Therapeutics (NASDAQ: RNTX) raises $50M, funds IPF trial into 2028 - Stock Titan
Rein Therapeutics, Inc.Common Stock (Nasdaq:RNTX) Stock Quote - The Chronicle-Journal
Rein Therapeutics (NASDAQ: RNTX) to sell 50M shares, nets ~$46.1M - Stock Titan
L. Lytton reports 4.5M shares in Rein Therapeutics (NASDAQ: RNTX) - Stock Titan
Rein Therapeutics stock dips after pricing $50M share offering - MSN
RNTX Slides As Rein Therapeutics Stock Tests New Lows - timothysykes.com
Rein Therapeutics Prices $50 Million Common Stock Offering; Shares Down Pre-Bell - Moomoo
Rein Therapeutics | EFFECT: Others - Moomoo
RNTX Stock Slides As Traders Eye Heavy Losses - timothysykes.com
Rein Therapeutics prices $50 million public offering at $1 - Investing.com
Rein Therapeutics prices $50 million public offering at $1 By Investing.com - Investing.com South Africa
Rein Therapeutics Inc prices public offering of 50 million shares at $1.00 per share for $50 million - marketscreener.com
Rein's $50M stock sale backs Phase 2 lung fibrosis study - Stock Titan
Rein Therapeutics' 50M-Share Offering Prices at $1 a Share - Moomoo
RNTX Ownership | REIN THERAPEUTICS INC (NASDAQ:RNTX) - ChartMill
RNTX (Rein Therapeutics) shares drop 12 percent after Q4 2025 EPS misses analyst estimates by a massive margin.Crowd Breakout Signals - Newser
Rein Therapeutics provides clinical trial update for Phase 2 ReNEW Study of LTI-03 in idiopathic pulmonary fibrosis - marketscreener.com
RNTX - Finviz
Rein Therapeutics Provides Clinical Trial Update For Phase 2 Renew Study Of Lti-03 In Idiopathic Pulmonary Fibrosis - TradingView
Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis - ChartMill
Rein Therapeutics (RNTX) to sell 30M shares to fund LTI‑03 trial - Stock Titan
Is Rein Therapeutics (RNTX) stock testing important levels | Q4 2025: Profit DisappointsCommunity Sell Signals - Newser
Rein Therapeutics, Inc. 2025 Executive Compensation, Director Pay, and Governance Details (10-K/A) - Minichart
Rein Therapeutics (NASDAQ: RNTX) details 2025 pay, ownership in 10-K/A - Stock Titan
Rein Therapeutics : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Rein Therapeutics Inc. (NASDAQ:RNTX) Short Interest Down 51.4% in April - MarketBeat
India's HCLTech forecasts weak annual revenue growth as clients rein in discretionary spends - Yahoo Finance
Is Rein Therapeutics (RNTX) stock gaining strength (Momentum Building) 2026-04-20Fast Rising Picks - Xã Vĩnh Công
RNTX Forecast, Price Target & Analyst Ratings | REIN THERAPEUTICS INC (NASDAQ:RNTX) - ChartMill
KCK LTD. Significantly Reduces Stake in Sight Sciences Inc - GuruFocus
Why Rein Therapeutics Inc. stock is a must watch in 20262026 Earnings Surprises & Stock Timing and Entry Methods - bollywoodhelpline.com
What are bearish arguments for Rein Therapeutics (RNTX) Stock | Price at $1.54, Up 0.65%Investment Picks - Newser
FY2026 EPS Estimate for Rein Therapeutics Lowered by Analyst - defenseworld.net
PTN PE Ratio & Valuation, Is PTN Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
BLRX PE Ratio & Valuation, Is BLRX Overvalued - Intellectia AI
RNTX Should I Buy - Intellectia AI
Rein 2026 10-K Report: Business Overview, Risk Factors, Pipeline, Competition, and Strategic Partnerships - Minichart
Rein Therapeutics 10-K: $0 Revenue, $0 Gross Profit; Net Loss $49.9M - TradingView — Track All Markets
Rein Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Rein Therapeutics (NASDAQ: RNTX) 10-K shifts focus to LTI-03 and flags 2026 funding needs - stocktitan.net
Rein Therapeutics Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
If You Invested $1,000 in Neuphoria Therapeutics Inc (NEUP) - Stock Titan
Rein Therapeutics Inc. (RNTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Decliners: What makes Rein Therapeutics Inc stock attractive today2026 Analyst Calls & High Accuracy Swing Trade Signals - baoquankhu1.vn
Risk Off: Can Rein Therapeutics Inc beat the S P 5002026 AllTime Highs & Smart Investment Allocation Insights - baoquankhu1.vn
Update Recap: Can Rein Therapeutics Inc sustain earnings growthEarnings Trend Report & Low Risk High Win Rate Picks - baoquankhu1.vn
Returns Recap: Can RenovoRx Inc expand its profit margins2026 Growth vs Value & Accurate Intraday Trade Tips - baoquankhu1.vn
Will Rein Therapeutics Inc. stock outperform international peersPortfolio Performance Summary & Daily Chart Pattern Signal Reports - Naître et grandir
What technical signals suggest for IDAI stockBond Market & Daily Stock Trend Watchlist - Naître et grandir
Finanzdaten der Rein Therapeutics Inc-Aktie (RNTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rein Therapeutics Inc-Aktie (RNTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 10% Owner |
Oct 28 '25 |
Buy |
1.39 |
178,392 |
247,965 |
500,000 |
| Voss Capital, LP | 10% Owner |
Oct 27 '25 |
Buy |
1.37 |
97,482 |
133,544 |
822,258 |
| Voss Capital, LP | 10% Owner |
Oct 24 '25 |
Buy |
1.39 |
30,176 |
41,957 |
729,616 |
5.78%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):